Nova Wealth Management’s Teva Pharmaceuticals TEVA Stock Holding History

Nova Wealth Management’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.42K	Buy	+42	New	+$1.4K	﹤0.01%	536

Other funds holding TEVA

Assenagon Asset Management

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Union Bancaire Privee Geneva 1, Switzerland $9.16B AUM 31.4% 1-Year Est. Return

Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return

Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return

Prospera Financial Services Dallas, Texas $6.89B AUM 37.41% 1-Year Est. Return

Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return

Rockingstone Advisors Great Barrington, Massachusetts $249M AUM 31.06% 1-Year Est. Return

Nova Wealth Management's TEVA Position: Q2 2026 in Review

Nova Wealth Management opened a new position in Teva Pharmaceuticals (TEVA) in Q2 2026: 42 shares worth $1.42K. The stake represents ﹤0.01% of the portfolio and ranks #536 among its holdings.

72 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

Nova Wealth Management held 42 shares of Teva Pharmaceuticals worth $1.42K as of Q2 2026.
Teva Pharmaceuticals was a new Nova Wealth Management position in Q2 2026.
Teva Pharmaceuticals made up ﹤0.01% of Nova Wealth Management's portfolio in Q2 2026, its #536 holding.
72 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Nova Wealth Management's 13F filing for Q2 2026, filed 13 Jul 2026.